[Combination of interferon alpha-1b, interleukin-2 and thalidomide as maintenance therapy on acute myeloid leukemia patients with negative minimal residual disease].

• Authors: L Chen, G P Li, R H Mi, F F Yuan, H Ai, Q Wang, Z F Wang, G J Wang, R H Fan, Q S Yin, X D Wei
• Journal: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi (Zhonghua Xue Ye Xue Za Zhi) Vol. 41 Issue 9 Pg. 766-769 (09 14 2020) ISSN: 0253-2727 [Print] China
• PMID: 33113610 (Publication Type: Journal Article)

Chemical References

• Antineoplastic Agents
• Interferon-alpha
• Interleukin-2
• Thalidomide

Topics

• Antineoplastic Agents (therapeutic use)
• Humans
• Interferon-alpha (therapeutic use)
• Interleukin-2 (therapeutic use)
• Leukemia, Myeloid, Acute (drug therapy)
• Maintenance
• Neoplasm, Residual
• Thalidomide (therapeutic use)